Literature DB >> 11153756

Beta-adrenoceptor stimulation attenuates the hypertrophic effect of alpha-adrenoceptor stimulation in adult rat ventricular cardiomyocytes.

M Schäfer1, K Pönicke, I Heinroth-Hoffmann, O E Brodde, H M Piper, K D Schlüter.   

Abstract

OBJECTIVES: The study investigated whether beta-adrenoceptor antagonists augment the hypertrophic response of cardiomyocytes evoked by norepinephrine.
BACKGROUND: In adult ventricular cardiomyocytes, stimulation of alpha- but not beta-adrenoceptors induces myocardial hypertrophy. Natural catecholamines, like norepinephrine, stimulate simultaneously alpha- and beta-adrenoceptors. We investigated whether beta-adrenoceptor stimulation interferes with the hypertrophic response caused by alpha-adrenoceptor stimulation.
METHODS: Adult ventricular cardiomyocytes isolated from rats were used as an experimental model. Hypertrophic parameters under investigation were stimulation of phenylalanine incorporation and protein mass, stimulation of 14C-uridine incorporation and RNA mass, and increases in cell shape.
RESULTS: Norepinephrine (0.01 to 10 micromol/liter) increased concentration-dependent phenylalanine incorporation; pEC50 value was 5.9 +/- 0.1 (n = 8). The alpha1-adrenoceptor antagonist prazosin (0.1 micromol/liter) suppressed norepinephrine-induced increase in rate of protein synthesis. Conversely, propranolol (1 micromol/liter) and the beta1-adrenoceptor selective antagonists CPG 20712A (300 nmol/liter) or atenolol (1 micromol/liter) augmented increases in phenylalanine incorporation caused by norepinephrine. Addition of the beta2-adrenoceptor antagonist ICI 118,551 (55 nmol/liter) did not influence the hypertrophic effect of norepinephrine. Atenolol augmented the norepinephrine-induced increases of all hypertrophic parameters investigated (i.e., protein mass, uridine incorporation, RNA mass, cell volume, and cross-sectional area). In the presence of norepinephrine, inhibition of beta1-adrenoceptors increased the amount of protein kinase C-alpha and -delta isoforms translocated into the particulate fraction. The effect of pharmacological inhibition of beta1-adrenoceptors could be mimicked by Rp-cAMPS (adenosine-3', 5'-cyclic phosphorothiolate-Rp). The inhibitory effect of beta1-adrenoceptor stimulation on the alpha-adrenoceptor-mediated effect persisted in cardiomyocytes isolated from hypertrophic hearts of rats submitted to aortic banding.
CONCLUSIONS: In isolated ventricular cardiomyocytes from rats, beta1-adrenoceptor stimulation attenuates the hypertrophic response evoked by alpha1-adrenoceptor stimulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11153756     DOI: 10.1016/s0735-1097(00)01065-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Enhanced SERCA2A expression improves contractile performance of ventricular cardiomyocytes of rat under adrenergic stimulation.

Authors:  A Anwar; K-D Schlüter; J Heger; H M Piper; G Euler
Journal:  Pflugers Arch       Date:  2008-06-26       Impact factor: 3.657

2.  Dynamic culture yields engineered myocardium with near-adult functional output.

Authors:  Christopher P Jackman; Aaron L Carlson; Nenad Bursac
Journal:  Biomaterials       Date:  2016-09-30       Impact factor: 12.479

3.  The signal transduction cascade regulating the expression of the gap junction protein connexin43 by beta-adrenoceptors.

Authors:  A Salameh; S Krautblatter; S Karl; K Blanke; D Rojas Gomez; S Dhein; D Pfeiffer; J Janousek
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

4.  Role of beta 1- and beta 2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes.

Authors:  Klaus Pönicke; Ingrid Heinroth-Hoffmann; Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-15       Impact factor: 3.000

5.  The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.

Authors:  Wolfgang Linz; Paulus Wohlfart; Manuel Baader; Kristin Breitschopf; Eugen Falk; Hans-Ludwig Schäfer; Martin Gerl; Werner Kramer; Hartmut Rütten
Journal:  Acta Pharmacol Sin       Date:  2009-06-08       Impact factor: 6.150

6.  Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes.

Authors:  M Fontana; H Olschewski; A Olschewski; K-D Schlüter
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

7.  Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.

Authors:  Klaus Pönicke; Ferdinand Gröner; Ingrid Heinroth-Hoffmann; Otto-Erich Brodde
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

8.  Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation.

Authors:  Robert S Haworth; Friederike Cuello; Metin Avkiran
Journal:  Basic Res Cardiol       Date:  2010-08-20       Impact factor: 17.165

9.  Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes.

Authors:  Gerhild Euler; Fabian Locquet; Joanna Kociszewska; Yvonne Osygus; Jacqueline Heger; Rolf Schreckenberg; Klaus-Dieter Schlüter; Éva Kenyeres; Tamara Szabados; Péter Bencsik; Péter Ferdinandy; Rainer Schulz
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-05       Impact factor: 3.727

10.  Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse.

Authors:  Stefano Toldo; Rachel W Goehe; Marzia Lotrionte; Eleonora Mezzaroma; Evan T Sumner; Giuseppe G L Biondi-Zoccai; Ignacio M Seropian; Benjamin W Van Tassell; Francesco Loperfido; Giovanni Palazzoni; Norbert F Voelkel; Antonio Abbate; David A Gewirtz
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.